Filing Details

Accession Number:
0001179110-13-017670
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-10 16:20:16
Reporting Period:
2013-12-06
Filing Date:
2013-12-10
Accepted Time:
2013-12-10 16:20:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
744218 Celldex Therapeutics Inc. CLDX In Vitro & In Vivo Diagnostic Substances (2835) 133191702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1255681 Shoos Karen Lipton C/O Celldex Therapeutics, Inc.
119 Fourth Avenue
Needham MA 02494
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-06 17,728 $8.16 31,061 No 4 M Direct
Common Stock Disposition 2013-12-06 17,728 $24.50 13,333 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option Disposition 2013-12-06 17,728 $0.00 17,728 $8.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-03-07 2015-03-07 No 4 M Direct